The US Food and Drug Administration (FDA) is recommending sponsors include a plan to enrol more participants from underrepresented racial and ethnic populations into clinical trials. Under the new guidance,…
Here, we explore the biggest social barriers to clinical trial accessibility from a patient recruitment perspective, as well as the benefits and drawbacks of technology in making research more accessible.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.